Boundless Bio pays $10 million to end San Diego lease early

nl.investing.com (Dutch)

Boundless Bio will pay $10 million to terminate its San Diego lease early, effective May 31, 2026. The company is exiting an 80,168-square-foot lab and office space lease that was set to expire in October 2034. The landlord has secured a new tenant, fulfilling a condition for the termination. This move aims to conserve cash as Boundless Bio manages its burn rate and advances its oncology pipeline, including a Phase 1 study for BBI-940.


With a significance score of 1.1, this news ranks in the top 56% of today's 33334 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers: